1. Data & Insights

Unlocking AI’s Promise in Patient Support Programs

Written by Posted on Less than 0 min read

Today’s guest post comes from Chris Apolito, Chief Strategy Officer, and Karina Castagna, Senior Vice President, Commercial Strategy at Mercalis.

Chris and Karina describe four ways that artificial intelligence (AI) can improve patient access, affordability, and adherence.

To learn more, join Mercalis for a complimentary webinar on March 13, 2025: Modernizing Patient Support: Harnessing Advanced Automation, Artificial Intelligence and Machine Learning to Improve Efficiency and Performance of PSPs.

Read on for Chris and Karina’s insights.


Read more »

© 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute, an HMP Global Company. All rights reserved. This Feed is for personal non-commercial use only.

       
View Original Article
Post Views: 99
Member since
Expert insights from Dr. Adam J. Fein on pharmaceutical economics and the drug distribution system. https://www.drugchannels.net/
Do you like Drug Channels's articles? Follow on social!

More from Drug Channels

  1. Trends & External Forces

The Top 15 Specialty Pharmacies of 2024: How PBMs, Health Systems, and Independents Are Shaping the Market (rerun)

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: What’s Next for Retail Pharmacy: Data, Debate, and Disruption. I’ll be joined by special guest Antonio Ciaccia, CEO of 46brooklyn Research, and President of 3 Axis Advisors. Click here to see the original post from April 2025. Drug Channels Institute’s […]
2 min read
0
  1. Data & Insights

Beyond Throughput: Building Reverification Strategies That Safeguard Access

Today’s guest post comes from Gregory Morris, Chief Strategy Officer at CareMetx. Gregory examines how Annual Reverification (AR) processes must evolve in response to changing payer dynamics and increasing benefit complexity. Rather than focusing solely on throughput and operational efficiency, he argues for the importance of more nuanced strategies that help ensure patients maintain access […]
2 min read
0
  1. Data & Insights

Mapping the Vertical Integration of Insurers, PBMs, Specialty Pharmacies, and Providers: DCI’s 2025 Update and Competitive Outlook (rerun)

This week, I’m rerunning some popular posts while I prepare for tomorrow’s live video webinar: What’s Next for Retail Pharmacy: Data, Debate, and Disruption. I’ll be joined by special guest Antonio Ciaccia, CEO of 46brooklyn Research, and President of 3 Axis Advisors. Click here to see the original post from April 2025. It’s time for […]
2 min read
0
  1. Data & Insights

Solving the Gross-to-Net Bubble With Better Data

Today’s guest post comes from Angie Franks, CEO at Kalderos. Angie examines how data fragmentation contributes to inefficiencies in drug discount programs and the broader gross-to-net bubble—the widening difference between a drug’s revenue at list prices and what manufacturers actually receive. Angie outlines how better access to consistent, claims-level data could help reduce waste, improve […]
2 min read
0
  1. Trends & External Forces

The Big Three PBMs’ 2026 Formulary Exclusions: MFP, Private Label Biosimilars, and Direct-to-Patient Threats for PBMs

For 2026, the three largest pharmacy benefit managers (PBMs)—Caremark (CVS Health), Express Scripts (Cigna), and Optum Rx (United Health Group)—have once again excluded hundreds of drugs from their standard formularies. Our updated counts appear below. The 2026 lists highlight how formulary preferences for Humira and Stelara are dominated by private-label biosimilars affiliated with the same […]
2 min read
0
  1. Data & Insights

The AI Advantage: When and Where to Apply It in Your Patient Support Program

Today’s guest post comes from William Grambley, Chief Product Officer at AssistRx.   William discusses four specific uses cases for how AI can create efficiencies and improve patient support programs for both healthcare providers and patients. He provides three considerations that life sciences organizations should evaluate when adopting AI in their patient support programs.   To […]
2 min read
0
  1. Data & Insights

Embedding Into the Provider’s Workflow is Key to a Specialty Drug’s Success

Today’s guest post comes from Nasir Ali, Chief Product Officer at CareMetx. Nasir reviews the cumbersome processes that affect providers’ preferences when prescribing a specialty drug to their patients. He believes that embedding the specialty drug initiation process into the provider’s workflow will benefit both patients and prescribers. Learn more by downloading CareMetx’s new 2024 […]
2 min read
0
  1. Trends & External Forces

Transparency vs. Reality: Troubling Lessons from PBM Disclosure Laws (rerun)

This week, I’m rerunning some popular posts while I prepare for today’s live video webinar: What’s Next for Retail Pharmacy: Data, Debate, and Disruption. I’ll be joined by special guest Antonio Ciaccia, CEO of 46brooklyn Research, and President of 3 Axis Advisors. Click here to see the original post from March 2025. Last week, President […]
2 min read
0
  1. Data & Insights

Three Ways GoodRx Is Helping Pharmacies Increase Profitability and Drive Innovation

Today’s guest post comes from Aaron Crittenden, President of Rx Marketplace at GoodRx. Aaron introduces us to GoodRx Community Link, a new offering from GoodRx that allows independent pharmacies to contract directly with GoodRx.  To learn about GoodRx Community Link, register for GoodRx’s free webinar on either June 3, 2025, or June 4, 2025. Both […]
2 min read
0
  1. Media & Marketing

Drug Channels News Roundup, December 2024: Crazy Medicare Reimbursements, Independents Grow (Really!), AFP Risks, Pharmacy History, GLP-1 Jokes, and Two Cool Dudes

Happy New Year, everyone! It’s been a huge year for Drug Channels Institute (DCI). In January, HMP Global acquired DCI. Thanks to our new friends at HMP, we will hold the Drug Channels Leadership Forum. This landmark event will take place in March 2025 in Miami. (If you haven’t done so yet, click here to […]
3 min read
0
  1. Data & Insights

Claritas Rx’s Webinar: Achieve Specialty Pharma Success with AI: Enhance Care, Elevate Fill Rates by 20% and Improve Patient Adherence

Participate in Claritas Rx’s upcoming webinar to learn innovative strategies designed to increase your fill rates by 20% and enhance patient adherence. The webinar seeks to elevate your operational efficiency and improve patient care standards.  Join Claritas Rx experts as they lead you through methods intended to optimize patient care coordination, featuring an in-depth real-world […]
3 min read
0
  1. Data & Insights

Hubs, AI, and the New Era of Revenue Protection in Patient Access

Today’s guest post comes from Steve Randall, Chief Technology Architect at ConnectiveRx. Steve examines how artificial intelligence (AI) is reshaping the role of patient support hubs in the specialty drug ecosystem. As policy, payer, and gross-to-net pressures mount, he argues that the hub model must evolve from a service function into a revenue-protection strategy—one that […]
2 min read
0
  1. Trends & External Forces

Drug Channels Leadership Forum 2026: Request an Invitation Before It’s Too Late!

The 2026 Drug Channels Leadership Forum (DCLF) is coming soon! Our second annual event will take place March 16–18, 2026, at the Turnberry Resort & Spa in Miami. Once again, Drug Channels Institute (DCI) is proud to host this invite-only gathering of senior leaders across the drug channel ecosystem. You must request an invitation to […]
3 min read
0
  1. Channel: Drug

Follow the 340B Dollar: Senator Cassidy Exposes How CVS Health and Walgreens Profit as 340B Contract Pharmacies (rerun)

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: Drug Channels Outlook 2026 . Today’s rerun provides background for the webinar, when I will discuss how the consequences of the Inflation Reduction Act for the 340B program and contract pharmacies. Click here to see the original post from May […]
2 min read
0
  1. Data & Insights

Hubs: The Bridge Between Patients and Providers

Today’s guest post comes from Josh Marsh, Vice President and General Manager, Sonexus™ Access and Patient Support at Cardinal Health. Josh examines the central role that hubs play in connecting patients, providers, and other stakeholders. He shares how hubs, by gathering and interpreting real-world insights, can help improve access, adherence, and the overall patient experience. […]
2 min read
0
  1. Media & Marketing

Drug Channels Leadership Forum: Full Agenda Now Available (Spoiler: It’s Awesome!)

I am pleased to announce the full agenda for the inaugural Drug Channels Leadership Forum, which will be held from March 17 to 19, 2025, at the Turnberry Resort and Spa in Miami. Everyone here at Drug Channels Institute (DCI) is excited to bring this novel event to the drug channels community. I personally assembled […]
3 min read
0
  1. Media & Marketing

Drug Channels News Roundup, October 2025: Vertical Integration Woes, AFPs Gone Wild, Part D’s Decline, 340Bloat, and Dr. G’s ACIP Haunting

Eeek! It’s time for the Drug Channels Halloween roundup of terrifying tales from the dark corners of the healthcare system. Gather your favorite demon hunters and help maintain the Honmoon. This month’s tricks and treats include: Vampiric! How vertically integrated insurers can drain the lifeblood from the U.S. healthcare system Boo! Chilling stories of the shady […]
2 min read
0
  1. Data & Insights

The Top 15 U.S. Pharmacies of 2024: Market Shares and Revenues at the Biggest Chains, PBMs, and Specialty Pharmacies

Next week, Drug Channels Institute (DCI) will release our 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. It’s the 16th edition of our popular and comprehensive examination of the entire U.S. drug pricing, reimbursement, and dispensing system. For 2024, DCI estimates that total prescription dispensing revenues at retail, mail, long-term care, and specialty […]
3 min read
0
  1. Holiday & Events

Drug Channels News Roundup, October 2024: Humira Price War Update, PA vs. Providers, IRA vs. Physicians, My AI Podcast, New DCI Jobs, and Dr. G on Copayments

Eeek! It’s time for Drug Channels’ Halloween roundup of terrifying tales to share with your ghoulish fiends. This month’s tricks and treats: Spooky! Blue Shield of California frightens away the gross-to-net bubble with its Humira biosimilar strategy Vampiric! Prior authorization sinks its fangs into providers’ time Wicked! How the IRA will put a stake through […]
2 min read
0
  1. Operations & Supply Chain

Five Crucial Trends Facing U.S. Drug Wholesalers in 2024 and Beyond

As regular readers of Drug Channels know, U.S. distribution and dispensing channels for prescription drugs are undergoing significant evolution and consolidation as the changing economics of pharmaceuticals challenge conventional business models. During this period of volatility, the core business model of the Big Three public pharmaceutical distribution companies—Cardinal Health, Cencora, and McKesson—remains intact. Put simply: […]
2 min read
0
Next